Skip to main content

Aggregator

Jade Bioscience Reports Preclinical Data For JADE301

2 hours 54 minutes ago
(RTTNews) - Jade Biosciences, Inc. (JBIO) announced preclinical data for JADE301, an investigational, anti-IFN-Beta monoclonal antibody being developed for dermatomyositis, a rare autoimmune disease that can cause skin inflammation and muscle weakness.
RTTNews

Jade Bioscience Reports Preclinical Data For JADE301

2 hours 54 minutes ago
(RTTNews) - Jade Biosciences, Inc. (JBIO) announced preclinical data for JADE301, an investigational, anti-IFN-Beta monoclonal antibody being developed for dermatomyositis, a rare autoimmune disease that can cause skin inflammation and muscle weakness.
RTTNews